猪AMPD1、MYF6基因的多态性及其与部分经济性状相关性研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
本试验以10个猪种/群,包括:外来品种杜洛克猪、大白猪、长白猪、湖南地方品种宁乡猪、湖南黑猪、大围子猪、沙子岭猪、海南五指山猪、杂种猪长大(LY)和杜长大(DLY)共923头猪为研究对象,采用PCR-RFLP方法分析了AMPD1基因、MYF6基因的遗传多态性及基因频率和基因型频率,并对品种间基因型频率进行了卡方检验。同时,结合屠宰性能记录,国内首次在猪上研究了AMPD1基因不同基因型对胴体性状和肉质性状的遗传效应,同时对MYF6基因不同基因型对胴体性状和肉质性状的遗传效应也做了相关研究。主要结果如下:
     1 AMPD1基因
     1.1在湖南地方猪种宁乡猪、大围子猪、沙子岭猪、五指山猪、湖南黑猪、三个外来猪品种、杜长大和长大十个猪种群体中,AMPD1基因的RsaI酶切位点均存在较丰富的多态性:宁乡猪、大围子猪、沙子岭猪、湖南黑猪和海南地方猪五指山猪中都检测到有从、AC、CC三种基因型个体的分布:在三个外来品种猪中,没有检测到CC基因型个体:在杂交猪群体中,AA基因型有较高分布,等位基因A为优势基因:
     1.2杜洛克、长白猪、大白猪、杜长大和长大猪在后腿比例性状上差异显著(P<0.05),AC基因型个体比AA基因型个体分别高:22.76%、16.80%、17.09%、21.95%、20.69%,选择AC型能提高后腿比例:在大白猪和长白猪中,在实测平均膘厚性状上,AC基因型个体比从基因型个体分别低:30%和26.36%,选择AC基因型能明显降低实测平均膘厚、提高瘦肉率;在杜洛克和长白猪中,选择AC基因型能显著的降低平均皮厚和脂率;
     1.3在失水率性状上,杜洛克、长白猪、大白猪、杜长大和长大杂交猪中,AC基因型个体比AA基因型个体分别低1.50%、6.68%、35.91%、1.25%和30.92%,选择AC基因型能降低失水率:在五个被检测的猪种/群体中,AC基因型的贮存损失高于从基因型的贮存损失。
     2 MYFd基因
     2.1在三个外国猪种群体以及长大、杜长大猪群体中,MYF6基因的MspI酶切位点均存在较丰富的多态性,而在地方品种中无多态性或多态性不明显;在湖南地方猪种及海南五指山猪中,没有检测到CC基因型个体,等位基因T为优势基因:在三个外来品种中,等位基因C为其优势基因,而且长白猪C等位基因频率最高,杜洛克最低;在长大和杜长大中优势基因为等位基因C;
     2.2杜洛克、长白猪、大白猪、杜长大和长大猪种/群体中,在脂率性状上,CC基因型个体比TT基因型个体分别低:97.06%、15.20%、10.67%、22.91%和19.61%,选择CC型能明显降低脂率;在大白猪和长大杂交猪中,在实测平均背膘厚性状上,CC基因型个体比TT基因型个体分别低:38.91%和:36.85%,CC基因型个体具有较薄的背膘厚和较高的瘦肉率,等位基因C具有一定的正效应;
     2.3在失水率性状上,C等位基因对大白猪具有增加失水率的负效应,而对长白猪有降低失水率的正效应,在其它猪种上,作用不明显;在贮存损失性状上,C等位基因具有增加贮存损失的负效应。
     本研究结果表明,AMPD1基因、MYF6因有望成为与背膘厚、瘦肉率、部分胴体性状和失水率及贮存损失性状相关的一个主要侯选基因或分子标记。
By adopting Polymerase Chain Reaction-Restrain Fragment Length Polymorphism(PCR-RFCP),the genetic variations of AMPD1 and MYF6 gene were detected in 923 pigs including 10 groups:Duroc,Yorkshire,Landrace,Hybrid breeds: DL Y(Duroc×Landrace×Yorkshire),LY(Landrace×Yorkshire),Ningxiang,Daweizi, Taoyuan、Shaziling、Wuzhishan.Then the genotype frequencies and gene frequencies were calculated according to the PCR-RFLP.The differences of genotype frequencies between groups were analyzed by Chi Square Test.At the same time,the effects on meat-quality traits and carcass traits of AMPD1 gene which was the first studied on pigs in China and MYF6 gene were estimated according to their slaughter datu.The main results are showed as follows:
     1.The genetic polymorphism and effect of AMPD1gene.
     1.1 There were great polymorphisms in RsaⅠrestriction loci of AMPD1 gene in Ningxiang,Daweizi,Shaziling,Taoyuan,Wuzhishan,three types of exotic-breeds. DLY and LY breeds;genotype AA,AC,CC were found in the native breeds Ningxiang,Daweizi.Shaziling,Taoyuan and Wuzhishan;genotype CC could be found in none of the exotic breeds:Duroc,Landrace and Yorkshire;Allele A was the superiority allele in the hybrid breeds;
     1.2 The traits of hind leg proportion were different in these five breeds:Duroc, Yorkshire,Landrace,DLY and LY.The individuals with AC genotype were taller by 22.76%,16.80%,17.90%,21.95%,and20.69%respectively than individuals with AA genotype's.If the AC genotype selected,the hind leg proportion would be enhanced. As to the traits of average fat thickness,the Yorkshire and Landrace individuals with AC genotype were lower than individuals with AA genotype by30%and26.36%,and If the AC genotype selected,the average fat thickness would be reduced and the lean percentage would be increased distinctly.On the two breeds of Duroc and Landrace,Selecting the AC genotype could reduce average skin thickness and fat percentage efficiently.
     1.3 Concerning the water loss traits of these five breeds:Duroc.Yorkshire, Landrace,DLYand LY,the individuals with AC genotype were lower than the ones with AA genotype by 1.50%,6.68%,35.91%,1.25%and 30.92%respectively,and Selecting the AC genotype could reduce the water loss.The AC genotype had significant higher in the drip loss than the AA 's.
     2.The genetic polymorphism and effects of MYF6 gene
     2.1 In the three types of exotic breeds and DLY,LY,there were great polymorphisms in MspⅠrestriction loci of MYF6 gene,whereas there were little or no polymorphisms in native breeds;in local breeds,there were no CC genotype and Allele T was the superiority allele;in the exotic breeds,Allele C was the superiority allele,and the highest frequency was Yorkshire,the lowest was Duroc;Allele C was the superiority allele in DLY and LY;
     2.2 With regard to trait of fat percentage,the individuals with CC genotype were lower than the ones with TT genotype by 97.06%,15.2%,10.67%,22.91%and 19.16% respectively.Selecting the CC genotype could reduce the fat percentage obviously.On the two breeds,Yorkshire and LY,individuals with CC genotype had lower average measured back fat thickness by 38.92%and 36.85%respectively than that of the ones with TT genotype.Individuals with CC genotype had thinner back fat thickness and higher lean percentage,and allele C took on certain positive effect.
     2.3 On the water loss trait of Yorkshire breed,Allele C operated negatively in increasing the Water loss percentage;while on the water loss trait of Landrace, Allele C operated positively in decreasing the water loss percentage.But the results were not so distinct on other breeds.On the trait of Drip loss,Allele C operated negatively in increasing Drip loss.
     The studies indicates that AMPD1 and MYF6 genes could be used as candidate genes or molecular marker related to the back fat thickness,lean percentage,partial carcass traits,water loss and drip loss traits.
引文
[1]施启顺,柳小春主编.养猪业中的杂种优势的利用[M].长沙:湖南科技出版社.1997.
    [2]鲁绍雄,吴常信.动物遗传标记辅助选择研究技其应用[J].遗传,2002.24(3):359-362:
    [3]Berta P,Hawkins JR,Sinclair AH.Genetic evidence equating SRY and the test-det-ermining factor[J].Nature,1990,348:448-453.
    [4]Sabina RL,Morisaki T,Clarke P,et al.eharacterization of the human and rat myoadenylate deaminase genes[J].J Biol Chem,1990,265(16):9423-9433.
    [5]Mahnke Zizelman DK,Dcunha J,Wojnar JM,etal.Regulation of rat AMP deaminase 3(isoform C)by development and skeletal muscle fibre type[J].Biochem J,1997,326(Pt2):521-529.
    [6]Mahnke-Zizelman DK,Sabinal RL.N-terminal sequence and distal histidine resi dues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E[J].J Biol Chem,2002,277(45):42654-42662.
    [7]Noumi T,MosherM E,Natori S,et al.A phenylalanine for serine subst- itution in the beta subunit of Escherichia coli F1-ATPase affects depen- dence of its activit3 on divalent cations[J].J Biol them,1984,259(16):10071-10075.
    [8]Ronca F,Ranieri-RaggiM,B town P E,et al.Evidence of a species - differentiated regulatory domain within the N-terminal region of skeletalmuscle AMP dearninase [J].Biochim BiophysActa,1994,1209(1 ):123-129.
    [9]Davide KJ,Khan AW.Estimation of inosinic acid in chicken muscle and its formation and degradation during post mortemaging[J].J Food Sci,1967,32:155.
    [10]Khan AW,Davide KJ,Lentz CP.Degradation of in osinic acid in chicken muscle d uring a septics to rage and its possible use as an index of quality[J].J Food Sci,1968,33:25.
    [11]Chow lS,Jacobson M.Inosine monophate,inosine and hypoxanthine in meat from broiler5,7 and 9 weeks of age[J].Poultry Science.1968.47:604.
    [12]刘望夷.肉用鸡肌肉肌苷酸含量的比较[J].中困农业科学?1980,13(4):79-83.
    [13]苏淑贞.不同品种猪肉肌苷酸含量的测定[J].中国畜牧杂志,1997,(4):13-15.
    [14]苏淑贞.鹌鹑、鸡、鸽子肌肉中肌苷酸含量的比较[J].家禽:1987,(2):32-33.
    [15]陈国宏,候水生,吴信生,等.中国部分地方鸡肌肉肌苷酸含量研究[J].畜牧兽医学报.2000,31(3):211-215.
    [16]Morisaki T,Gross M.Morisaki H.et al.Molecular basis of AMPdeaminase de ficiency in skeletalmuscle[J].Proc NatlAcad Sci.1992.89(14):6457-6461.
    [17]Strail A,Knoll A.Moser G.et al.The porcine adenosine monophosphate deaminasel (AMPD1)gene maps to chromosome 4[J].Anim Genet,2000,31(2):147-148.
    [18]Sabina RL,Marquetant R,DesaiNM,et al.Cloning and sequence of rat myoadenylate deaminase cDNA:evidence for tissue-specific and developmental regulation[J].J Biol Chem,1987,262(26):12397- 12400.
    [19]Sabina RL,Morisaki T,Clarke P,et al.Characterization of the human and rat myoadenylate deaminase genes[J].J BiolChem,1990,265(16):9423-9433.
    [20]柴丽鹃.AMPD1多态性与肉质性状的相关研究[C].太原:山西农业大学,2003.
    [21]Morisaki T,Gross M,Morisaki H,et al.Molecular basis of AMP deaminase deficiency in skeletal muscle[J].Proc Natl Acad Sci USA.1992,89(14):6457-6461.
    [22]Baumeister FA,Gross M,Wagner DR,etal.Myoadenylate deaminase deficiency with severe rhabdomyolysis[J].Eur J Pediatr.1993,152(6):513-515.
    [23]Morisaki H,Morisaki T,Newby LK,et al.Alternative splicing:a mechanism for phenotypic rescue of a common inherited defect[J].J Clin Invest.1993,91(5):2275-2280.
    [24]Gross M,Morisaki H,Morisaki T,et al.Identification of functional domains in AMPD1by mutational analysis[J].Biochem Biophys Res Commun.1994,205(2):1010-1017.
    [25]Fortuin FD,Morisaki T.Holmes EW.Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle[J].Proc Assoc Am Physicians.1996,108(4):329-333.
    [26]Fishbein WN,Davis JI.Foellmer JW,et al.A Competitive Allele-specific Oligomers Polymerase Chain Reaction Assay for the cis Double Mutation in AMPD1 That Is the Major Cause of Myo-adenylate Deaminase Deficiency[J].Mol Dia gn.1997,2(2):121-128.
    [27]Gross M.Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency[J].J Inherit Metab Dis.1997,20(2):186-192.
    [28]Loh E,Rebbeck TR,Mahoney PD,et al.Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart fai lure[J].Circulation.1999,99(11):1422-1425.
    [29]Feldman AM,Wagner DR,McNamara DM.AMPD1 gene mutation in congestive heart failure:new insights.into the pathobiology of disease progression[J].Circulation.1999,99(11 ):1397-1399.
    [30]Morisaki H,Higuchi I,.Abe M.et al.First missense mutations(R388W and R425H)of AMPD1 accompanied with myopathy found in a Japanese patient[J].Hum Murat.2000,16(6):467-472.
    [31]Abe.M.Higuchi l,Morisaki H.et al Myoadenytate deaminase deticiency with.progressive muscle weakness and atrophy caused by new missense mutations in AMPD1gene:case report in a Japanese patient[J].Neuromuscul Disord.2000.10(7):472-477.
    [32]Rubio JC,Martin MA,Del Hoyo P,et al.Moleeular analysis of Spanish patients with AMP deaminase defieieney[J].Muscle Nerve.2000,23(8):1175- 1178.
    [33]Anderson JL,Habashi J,Carlquist JF,et al.A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease[J].J Am Coil Cardiol.2000,36(4):1248-1252.
    [34]Norman B,Sabina RL,Jansson E.Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatie subjects[J].J Appl Physiol.2001,91(1):258-264.
    [35]Gross M,Rotzer E,Kolle P,et al.A G468-T AMPD1 mutant allele contributes to th e high incidence of myoadenylate deaminase deficiency in the Caucasian population [J].Ne uromuseul Disord.2002,12(6):558-565.
    [36]Arenas J,Martin MA.Metabolic intolerance to exercise[J].Neurologia.2003,18(6):291-302.
    [37]Rieo-Sanz J,Rankinen T,Joanisse DR,et al.Associations between eardiore spiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study[J].Physiol Genomics.2003,14(2):161-166.
    [38]Kalsi KK,Yuen AH,Rybakowska IM,et al.Deereased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation-a potential mechanism of protection in heart failure[J].Cardiovase Res.2003,59(3):678-684.
    [39]Toyama K,Morisaki H,Kitamura Y,ea al.Haplotype analysis of human AMPD1gene:origin of common mutant allele[J].J Med Genet.2004,41(6):e74.
    [40]Gastmann A,Sigusch HH,Henke A,et al.Role of adenosine monophosphate deaminase-1gene polymorphism in patients with congestive heart failure(influence on tumor necrosis factor-alpha level and outeome)[J].Am J Cardiol.2004,93(10):12.60-1264.
    [41]Binkley PF,Auseon A,Cooke G.A polymorphism of the gene encoding AMPDI:clinieal impact and proposed mechanisms in congestive heart failure[J].Congest Heart Fail.2004:10(6):274-78;quiz 279-280.
    [42]Finsterer J,Schoser B,Stollberger C.Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction[J].Acta Car diol.2004,59(4):453-456.
    [43]Yacoub MH,Yuen AH,Kaisi kK,et al.C34T AMP deaminase 1.gene mutation protects cardiac function in donors[J].Transplantation.2004,77(10):1621-1623.
    [44]Yazaki Y,Muhlestein JB,Carlquist JF,.t al.A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction[J].J Card Fail.2004,10(4):316-320.
    [45]Andreassi MG,Botto N,Laghi-Pasini F,et al.A MPD1(C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization[J].Int J Cardiol.2005,101(2):191-195.
    [46]Rubio JC,Martin MA,Rabadan M,et al.Frequency of the C34T mutation of the AMPD1gene in world-class endurance athletes:does this mutation impair performance [J].J Appl Physiol.2005,98(6):2108-2112.
    [47]Kolek MJ,Carlquist JF,Thaneemit-Chen S,et al.The role of a common adenosine monophosphate deaminase(AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure[J].J Card Fail.2005,11(9):677-683.
    [48]Kalsi KK,Yuen AH,Johnson PH,et al.AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart[J].Nucleosides Nucleotides Nucleic Acids.2005,24(4):287-288.
    [49]Goodarzi MO,Taylor KD,Guo X,et al.Variation in the gene for muscle-specific AMP -deaminase is associated with insulin clearance,a highly heritable trait[J].Diabetes.2005,54(4):1222-1227.
    [50]Isackson PJ,Bujnicki H,Harding CO,et al.Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene[J].Mol Genet Metab.2005,86(1-2):250-256.
    [51]Wessels JA,Kooloos WM,DeJonge R,et al.Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent -onset rheumatoid arthritis[J].Arthritis Rheum.2006,54(9):2830-2839.
    [52]Collins RP,Palmer BR,Pilbrow AP,et al.Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial-infarction patients[J].Am Heart J.2006,152(2):312-320.
    [53]Hand BD,Roth SM,Roltsch MH,et al.AMPD1 gene polymorphism and the vasodilatory response to ischemia[J].Life Sci.2006,79(15):1413-1418.
    [54]Morisaki T,Sabina RL.Holmes EW.Adenylate deaminase.A multigene family in humans and rats[J].J Biol Chem.1990.265(20):11482-11486.
    [55]Mineo l,Clarke PR,Sabina RI,et a I.A novel pathway for alternative splicing:identification of an RNA intermediate that generates an alternative 5'splice donor site not present in the primary transcript of AMPDI[J].Mol Cell Biol.I990,10(10):5271-5278.
    [56]Mineo l,Holmes EW.Exon recognition and nucleocytoplasmic partitioning determine AMPD1 alternative transcript production[J].Mol Cell Biol.1991,11(10):5356-63.
    [57]Hisatome I,Morisaki Y,Kamma H,et al.Control of AMPdeaminase I binding to myosin heavy chain.Am J Physiol.1998,275(3Pt1):C870-881.
    [58]张学余,季从亮,陈国宏,等.6个鸡种腺苷单磷酸脱氨酶1基因克隆及序列分析[J].云南农业大学学报,2004,19(2):224-227.
    [59]罗桂芬,陈继兰,孙世铎,等.鸡AMPD1基因PCR-SSCP分析与相关性状的研究[J].黑龙江畜牧兽医,2005,4:8-10.
    [60]柴丽娟,储明星,文杰,等.北京油鸡AMPD1基因多态性及其与肌苷酸含量关系的研究[J].畜牧兽医学报,2005,36(11),1117-1120.
    [61]Arnold HH,Winter B.Muscle differentiation:more complexity to the network of myogenic regulators[J].Curr Opin Genet Dev 1998,8(5):539-544.
    [62]Hawke TJ,Garry DJ.Myogenic satellite cells:physiology to molecular biology[J].J Appl Physio 2001,91:534-551.
    [63]Rudnicki MA,Braun T,Hinuma S,et aI.Iactivation of MyoD in mice leads to upregulation of the myogenic HLH gene Myf-5 and results in apparently normal muscledevelopment [J].Cell 1992,71(3):383
    [64]Braun T,Rundinicki MA,Amold HH,et al.Targeted inactivation of the mouse regulatory gene Myf5 results in abnormal distal rib development and early postnatal death in homoxygous mouse mutant[J].Cell 1992,71:369.
    [65]Rudinick BT,Hinuma S,Jaenish R.MyoD or Myf5 is required for the formation of skeletal muscle[J].Cell 1993,75:1351.
    [66]Cooper RN,Taybukhsh S,Mouly G,et al.In vivo satellite cell activation via Myf-5and MyoD in regenerating mouse skeletal muscle[J].J Cell Sci 1999,112:2895.
    [67]Hasty P,Bradley A,Morris JH.Muscte deficiency and neonatal death in mice with a targeted mutation in the myogenin gene[J].Nature 1993,64(6437):501-506.
    [68]Zhang MG,Olson EN,Behringer RR.Inactivation of the myogenic gene MRF4 resuits in up-regulation of myogenin and rib anomalies[J].Genes and Dev 1995,9(11):1388-1399.
    [69]Megeney LA.Rudinicki MA.Determinayion versus differetiation and the MyoD family of tyascription factors[J].Biochem Cell Biol 1995.73(9-10):723-732.
    [70]Megeney LA,Kablar B.Garrett K.et al.MyoD is required for myogenic stem cell function in adult skeletal muscle[J].Genes Dev,1996,10:1173-1183.
    [71]Rhodes SJ,Konieczny SF.Identification of MRF4:a new member of the muscle regulatory factor gene family[J].Gen Dev.1989 Dec,3(12B):2050-2061.
    [72]Hinterberger TJ,Sassoon DA,Rhodes SJ,et at.Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development[J].Dev Biol.1991Sep,147(1):144-156.
    [73]Hinterberger TJ,Mays JL,Konieczny SF.Structure and myofiber-specific expression of the rat muscle ragulatory gene MRF4[,1].Gene.1992 Aug,117(2):201-207.
    [74]Kerkvliet CM,Hinterberger TJ.Distal regulatory regions of the rat MRF4 gene[J].Biochem Biophys Res Commun.1997 Aug,237(1):170-176.
    [75]Weis J,Kaussen M,Calvo S,et al.Denervation induces a rapid nuclear accumulation of MRF4 in mature myofibers[C].Developmental dymamics:an official publication of the American Association of Anatomists,2000.
    [76]Zhou Z,Bornemann A.MRF4 protein expression in regenerating rat muscle[J].Journal of muscle reaserch and Cell motility.2001,22(4):311-316.
    [77]Pavlath GK,Dominov JA,Kegleg KM,et at.Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4[J].The animal Journal of Pathology.2003 May,162(5):1685-1691.
    [78]Carvalho RF,Cicogna AC,Campos GE,et al.Heart failure alters MyoD and MRF4expressions in rat skeletal muscle[J].International Journal of experimental Pathology.2006 Jun,87(3):219-225.
    [79]Ernst CW,Vaske DA,Larson RG,et al.Rapid communication:MspI restriction fragment length polymorphism at the swine MYF6 locus[J].J Anim Sci.1994 Ma r,72(3):799.
    [80]Vykoukalova Z,Knoll A,Dvorak J,et al.Linkage and radiation hybrid mapping of the porcine MYF6 gene to chromosome 5[J].Anim Genet.2003 Jun,34(3):238-240.
    [81]Wyszynska-koko J,Kuryl J.Porcine MYF6 gene:sequence,homology analysis,and variation in the promoter region[J].Anim Bioteclmol.2004,15(2):159-173.
    [82]朱砺,李学伟.MYF6基因在不同猪种的PCR-RFLP遗传多态性及其遗传效应分析[J].遗传.2005.27(6):887-892.
    [83]Maak S.Neumann K,Swalve HH.Identification and analysis of putative regulatory sequences for the MYF5/MYF6 locus in different vertebrate species[J].Gene.2006 Sep,379:141-147.
    [84]Wyszynska-koko J.Pierzchala M.Rozycki M.et al.Polynaorphisms in coding and regulatory regions of the porcine MYF6 and MyoG genes and expression of the MY-F6gene in m.longissimus dorsi versus productive traits in pigs[J].Journal of applied genetics.2006.47(2):131-138.
    [85]孙文浩,朱庆,蒋小松等.鸡Myf6基因遗传多态性及其遗传效应研究[J].遗传.2008,30(1):71-76.
    [86]Ryan AM,Schelling CP,Womack JE,et al.Chromosomal assignment of six musclespecific genes in cattle.Anim Genet.1997Apr,28(2):84-87.
    [87]Hansen GR,Abbey CA,Gaile DP,et al.Assignment of six genes to bovine chromosomes5and 16 by fluorescence in situ hybridization,radiation hybrid mapping and genetic linkage analysis[J].Cytogenet Genome Res.2007,116(3):194-197.
    [88]Jennings CG.Expression of the myogenic gene MRF4 during Xenopus development [J].Dev Biol.1992 May,151(1):319-332.
    [89]施启顺.猪的分子标记辅助育种[J].国外畜牧学:猪与禽,2001,(2):21-23.
    [90]吴常信,李宁.分子生物技术在中国动物育种中的应用[J].中国家禽,2002,24(13):6-9.
    [91]彭中镇,赵书红.猪数量性状基因及其标记研究进展[J].国外畜牧科技,1999,25(1):28-32.